Hong Kong Stocks Movement | PEGBIO CO-B (02565) Surges Over 6% After Receiving Lock-Up Extension Notice from Cornerstone Investors

Stock News2025-12-24

PEGBIO CO-B (02565) rose more than 6%, reaching 5.94% at the time of writing, with its stock price at HK$65.95 and a trading volume of HK$5.08 million.

The company announced that the original lock-up period, which had been extended once before, was set to expire on December 31, 2025. As of the announcement date, cornerstone investors collectively held 9.58 million H-shares, representing approximately 3.43% of the company's total issued H-shares.

Recently, the company received a notice from cornerstone investors stating their agreement not to sell any related H-shares in any manner from the original lock-up expiration date (previously extended) until April 30, 2026.

PEGBIO CO-B views this second lock-up extension as a sign of confidence from cornerstone investors in the company's future prospects, driven by its progress in R&D capabilities and significant clinical milestones. The cornerstone investors will continue to review the company's performance and may consider further extending the lock-up period based on real-time developments and achieved milestones.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1168629267?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-24 11:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1168629267","market":"hk","top_or_hot":-1,"title":"Hong Kong Stocks Movement | PEGBIO CO-B (02565) Surges Over 6% After Receiving Lock-Up Extension Notice from Cornerstone Investors","media":"Stock News","content":"<p>PEGBIO CO-B (02565) rose more than 6%, reaching 5.94% at the time of writing, with its stock price at HK$65.95 and a trading volume of HK$5.08 million.</p>\n<p>The company announced that the original lock-up period, which had been extended once before, was set to expire on December 31, 2025. As of the announcement date, cornerstone investors collectively held 9.58 million H-shares, representing approximately 3.43% of the company's total issued H-shares.</p>\n<p>Recently, the company received a notice from cornerstone investors stating their agreement not to sell any related H-shares in any manner from the original lock-up expiration date (previously extended) until April 30, 2026.</p>\n<p>PEGBIO CO-B views this second lock-up extension as a sign of confidence from cornerstone investors in the company's future prospects, driven by its progress in R&D capabilities and significant clinical milestones. The cornerstone investors will continue to review the company's performance and may consider further extending the lock-up period based on real-time developments and achieved milestones.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong Stocks Movement | PEGBIO CO-B (02565) Surges Over 6% After Receiving Lock-Up Extension Notice from Cornerstone Investors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong Stocks Movement | PEGBIO CO-B (02565) Surges Over 6% After Receiving Lock-Up Extension Notice from Cornerstone Investors\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-12-24 11:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>PEGBIO CO-B (02565) rose more than 6%, reaching 5.94% at the time of writing, with its stock price at HK$65.95 and a trading volume of HK$5.08 million.</p>\n<p>The company announced that the original lock-up period, which had been extended once before, was set to expire on December 31, 2025. As of the announcement date, cornerstone investors collectively held 9.58 million H-shares, representing approximately 3.43% of the company's total issued H-shares.</p>\n<p>Recently, the company received a notice from cornerstone investors stating their agreement not to sell any related H-shares in any manner from the original lock-up expiration date (previously extended) until April 30, 2026.</p>\n<p>PEGBIO CO-B views this second lock-up extension as a sign of confidence from cornerstone investors in the company's future prospects, driven by its progress in R&D capabilities and significant clinical milestones. The cornerstone investors will continue to review the company's performance and may consider further extending the lock-up period based on real-time developments and achieved milestones.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"399441","symbol_name":"生物医药","start_time":0,"source_url":"","article_id":"1168629267","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1168629267","pubTimestamp":1766545941,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"PEGBIO CO-B (02565) rose more than 6%, reaching 5.94% at the time of writing, with its stock price at HK$65.95 and a trading volume of HK$5.08 million. The company announced that the original lock-up...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"161726":"生物医药","399441":"生物医药","BK1161":"生物科技","02565":"派格生物医药-B"},"translate_title":"港股动向|派格生物CO-B(02565)接获基石投资者锁定延期通知后急升超6%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"161726":1,"399441":1,"02565":1},"content_text":"PEGBIO CO-B (02565) rose more than 6%, reaching 5.94% at the time of writing, with its stock price at HK$65.95 and a trading volume of HK$5.08 million.\nThe company announced that the original lock-up period, which had been extended once before, was set to expire on December 31, 2025. As of the announcement date, cornerstone investors collectively held 9.58 million H-shares, representing approximately 3.43% of the company's total issued H-shares.\nRecently, the company received a notice from cornerstone investors stating their agreement not to sell any related H-shares in any manner from the original lock-up expiration date (previously extended) until April 30, 2026.\nPEGBIO CO-B views this second lock-up extension as a sign of confidence from cornerstone investors in the company's future prospects, driven by its progress in R&D capabilities and significant clinical milestones. The cornerstone investors will continue to review the company's performance and may consider further extending the lock-up period based on real-time developments and achieved milestones.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1168629267","isCrawlerRequest":true}